For example, PPI use has been associated with inferior survival in colorectal cancer patients, possibly related to changes in fecal microbiota, increase in gastrin secretion with colonic polyp progression, and hypothetical endothelial function alterations [31–36]. The gene discussed is GAST; the disease is colorectal cancer.